News

Skin cancer is the most common cancer in the United States, with an estimated 1 in 5 Americans developing skin cancer in their lifetime. This summer season, Megan McNally, MD, a fellowship-trained surgical oncologist with Saint Luke's Cancer Institute, joined KCTV to share helpful insights on skin safety.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.